Registration is now open for the two-day Brain Innovation Days event, to be held physically in Brussels, Belgium, on 12-13 October.
EAN Congress 2025 relocated to HELSINKI due to UN summit (dates remain 21-24 June)
September 20, 2024
Due to unforeseen developments, the 11th Congress of the European Academy of Neurology has been relocated and will now be held in Helsinki on June 21-24, 2025.
EAN co-hosting G7 side-event in Ancona, Italy, on 8 October
September 13, 2024
Upcoming Joint Sessions at Partner Societies’ Congresses
August 26, 2024
Latest Posts
-
-
EAN NewsEBC
EPICLUSTER event on patient involvement in epilepsy research, 6 October
September 20, 2021EPICLUSTER will hold its 3rd activity on Accelerating Patient Involvement in European Epilepsy Research on 6 October from 9:30 to 13:00 CET -
News in generalTop Articles
New European Commission call for member to represent health professional organisations
September 20, 2021Call from the European Commission for a member representing health professionals and one alternate for the EMA's Pharmacovigilance Risk Assessment Committee (PRAC). -
Breaking newsResearchCOVID-19
Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19
September 15, 2021Breaking News by Dementia and cognitive disorders Panel -
EAN NewsNews in general
EAN joint session at 37th ECTRIMS Congress to focus on vaccination and treatment guidelines for people with multiple sclerosis
September 13, 2021This year, at the upcoming 37th ECTRIMS congress, the ECTRIMS-EAN Session, chaired by Profs. Massimo Filippi, Mar Tintoré, Maria Pia Amato and Celia Oreja-Guevara, will discuss two key aspects of MS management: the consensus regarding vaccinations in people with MS and the updated guidelines for MS treatment. -
Breaking newsCOVID-19
Impulse Control Disorders in Parkinson’s Disease: Has COVID-19 Related Lockdown Been a Trigger?
September 7, 2021Retrospective analysis of consecutive PD patients seen in an outpatient Movement Disorders Clinic during 2 months, to explore the frequency of ICD during the preceding 2-month lockdown period, and comparison with an equivalent control group. -
Breaking newsCOVID-19
Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study
September 7, 2021In this article the authors aimed to uncover if headache patients develop more headaches after COVID-19 mRNA vaccination than healthy controls. -
Breaking newsCOVID-19
Autonomic dysfunction in post-COVID patients with and without neurological symptoms: a prospective multidomain observational study
September 7, 2021The aim of the present study was to administer the COMPASS-31 questionnaire to a sample of post-COVID patients with and without neurological complaints. -
Breaking newsCOVID-19
SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19
September 7, 2021In this article the authors present a systematic review, carried out according to the Preferred Reporting Items for Systematic Review standards, of the neuropathological features of COVID-19. -
Breaking newsCOVID-19
Cognitive Impairment After COVID-19—A Review on Objective Test Data
September 7, 2021The aim of this study was to conduct a review on the literature on objective cognitive impairment in patients after COVID-19. -
Breaking newsCOVID-19
Worsened Parkinson’s Disease Progression: Impact of the COVID-19 Pandemic
September 7, 2021In this study the authors retrospectively analyzed motor symptoms of longitudinally followed PD patients (n = 264) and compared motor disease progression before and during the COVID-19 pandemic. -
Breaking newsCOVID-19
Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease
September 7, 2021Review of literature regarding mechanisms of acute and chronic neurological disorders in association with COVID-19. -
Breaking newsCOVID-19
Interpretation of vaccine associated neurological adverse events: a methodological and historical review
September 7, 2021In this review, the authors discuss contemporary methodologies employed to investigate possible associations between vaccination and adverse neurological outcomes and why determining causality can be challenging. -
Breaking newsCOVID-19
Neurological comorbidities and COVID-19-related case fatality: A cohort study
September 7, 2021This cohort study evaluates the COVID-19-related case fatality rate (CFR) of patients with pre-existing neurological diseases. -
Breaking newsCOVID-19
Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: A critical systematic review
September 7, 2021In this article the authors performed a systematic literature review on neuropathological studies in COVID-19, including 438 patients from 45 articles published by April 22, 2021.